Current studies have confirmed that the patients with mutations in TSC2 have systemic multisystem involvement, compared with mutations in TSC1.[18] In terms of neurological manifestations, the patients with mutations in TSC2 showed higher levels of seizure, autism and intellectual disability than did the patients with mutations in TSC1, and the symptoms of seizure are more severe. The gene discussed is TSC1; the disease is Intellectual disability.